Shark Attack Off Queensland Coast Raises Safety Concerns for Tourism Sector Coal India OFS Opens for Retail Investors at 11 Discount Key Details Ferrari Unveils Luce First Fully Electric Car at 640000 Shares Slip Amid Market Skepticism CBRS Spectrum Drives US Manufacturing Transformation Industry Data Highlights Indias Gen Z Discontent Fuels Cockroach Movement Amid Website Takedown DeepSeek Chinese AI Model Impresses Silicon Valley with Limited Hardware PPC Q1 2026 Earnings EPS Miss Hits Investor Sentiment as Profit Falls Short of Estimates CDRO Q4 2025 Earnings Narrowing Losses but EPS Misses Estimates Sharply TXG Q1 2026 Earnings EPS Beat Masks Revenue Uncertainty as Stock Declines SAM Q1 2026 Earnings EPS Misses Estimates Amidst Persistent Cost Headwinds POWI Q1 2026 Earnings EPS Surpasses Estimates Stock Declines 426 MU Q1 2026 Earnings Strong EPS Beat Drives 19 Stock Surge RenX Enterprises RENX Surges 113 Key Levels and Potential Drivers Nuveen Municipal Credit Income Fund NZF Rises Modestly as Steady Demand Supports FixedIncome Assets OI Glass OI Slips 2 as Packaging Sector Faces Headwinds Key Support at 839 in Focus Alzamend Neuro ALZN Slides 174 as Stock Tests Key Support at 107 Northwest Natural Holding NWN Edges Lower Amid Modest Trading Key Levels in Focus Indonesian Commodity Exporters Cite Multiple Obstacles in State Monopoly Proposal DWSN Q2 2019 Earnings EPS Misses Estimates Amid Challenging Energy Market Conditions Crane Harbor Acquisition Corp II Rights CRANR Drifts Sideways at 021 Support and Resistance Tighten Vanguard Total International Stock Index Fund ETF VXUS Gains Attention as Graham Stephan Portfolio Pick BLTE Q4 2025 Earnings WiderthanExpected Loss as PreRevenue Biotech Remains Focused on Clinical Development CNI Q1 2026 Earnings Earnings Beat Driven by Operational Efficiency as Revenue Data Unavailable EOG Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline Intuit to Cut 17 of Workforce Shifting Focus to AI Amid Tax Business Disruption Concerns Pokmon Card Boom Nostalgia Speculation and HighProfile Investors Drive MillionDollar Sales Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues